BIOTRICITY INC. — Income Charts
2 years of history · ending 2025-03-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$14M
Cost of Revenue
$3M
Gross Profit
$11M
R&D
$2M
SG&A
$11M
D&A
$6K
Operating Income
$-2M
EBITDA
$-2M
Interest Expense
$3M
Other Income/Expense
$-3M
Pretax Income
$-8M
Tax Provision
—
Net Income
$-8M
Gross Margin
76.6%
Operating Margin
-17.8%
Net Margin
-61.1%
Deferred Tax Assets
—
DTA Valuation Allowance
$19M
NOL Carryforwards
$73M
ETR Federal Statutory
26.0%
ETR State + Local (pp)
—
Revenue YoY Variation
14.3%
Income YoY Variation
72.3%